Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase I
IMV Inc. to Present at Upcoming Investor Conference
Phase III
Kodiak Sciences to Host R&D Day on October 14 in San…
Phase I
Roche Vice Chairman Calls for Long-Term Thinking by Business to Save…
Approval
Marizyme Agrees to Distribute Somahlution’s DuraGraft Products in South America and…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
European Results From Global ETNA-AF Registry Show Low Bleeding and Low…
Deals
Some EpiPen and EpiPen Jr auto-injectors may be difficult to remove…
Lay off/Spin-off/Appointments
AbbVie Stays Busy While Working to Complete Allergan Acquisition
Lay off/Spin-off/Appointments
Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim…
Home
Commercial
Lay off/Spin-off/Appointments
Lay off/Spin-off/Appointments
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Lay off/Spin-off/Appointments
AbbVie Stays Busy While Working to Complete Allergan Acquisition
Biospace News
-
October 11, 2019
Lay off/Spin-off/Appointments
Aridis Pharmaceuticals Appoints Infectious Disease Expert Paul Mendelman, MD as Interim Chief Medical Officer
Lay off/Spin-off/Appointments
Datavant and Parexel Partner to Harness Real-World Evidence
Lay off/Spin-off/Appointments
Aurinia Announces Further Strengthening of the Senior Management Team
Lay off/Spin-off/Appointments
Gilead CSO, Other Executives, Departing Company as CEO Continues to Reshape C-Suite
Lay off/Spin-off/Appointments
Inovio, Amneal Slash Workforces as Both Companies Undergo Realignments
Biospace News
-
July 17, 2019
0
Lay off/Spin-off/Appointments
Checkmate Pharmaceuticals Announces Appointment of Alan Fuhrman to Board of Directors
Biospace News
-
July 16, 2019
0
Lay off/Spin-off/Appointments
Immunic, Inc. Appoints Sanjay S. Patel, CFA, as Chief Financial Officer
Biospace News
-
July 16, 2019
0
Lay off/Spin-off/Appointments
Akebia Therapeutics CEO, John P. Butler, Elected Chair of Kidney Care...
Biospace News
-
July 11, 2019
0
Lay off/Spin-off/Appointments
Ampio Appoints Moss Adams LLP as the Company’s New Independent Auditor
Biospace News
-
July 11, 2019
0
1
2
3
...
27
Page 1 of 27
- Advertisement -
MOST POPULAR
Moleculin Announces Successful Expansion of its Leukemia Drug Program
April 9, 2019
Heron Announces FDA Approval of Supplemental New Drug Application to Expand...
February 26, 2019
Alligator Bioscience: Preclinical data on the tumor-localizing anti-CTLA-4 antibody ATOR-1015 published...
April 12, 2019
2 Potential Blockbusters: AbbVie’s Pipeline Looks Promising
March 27, 2019
Load more
HOT NEWS
Phase III
SpringWorks Therapeutics Announces Initiation of Phase 3 Trial (DeFi) of Nirogacestat...
Deals
Spero Therapeutics Announces Collaboration with Bill & Melinda Gates Medical Research...
Phase III
Lundbeck and Otsuka’s Antipsychotic Drug Rexulti Fails Two Bipolar Phase III...
Approval
Chinese Regulatory Authority [NMPA] Approves IND Application of Oramed’s Oral Insulin...
